The Children's Hospital of Philadelphia;The Childrens Hospital of Philadelphia
发明人:
Hakonarson, Hakon,Kao, Charlly
申请号：
AU2016318786
公开号：
AU2016318786A1
申请日:
2016.09.07
申请国别(地区):
AU
年份:
2018
代理人:
摘要：
Methods and uses for diagnosing and treating anxiety disorders are encompassed, wherein diagnosis and treatment may be based upon an assessment of genetic alterations in metabotropic glutamate receptor (mGluR) network genes and wherein treatment is with nonspecific activators of mGluRs such as fasoracetam.
